Page 34 - HTX Kompendium
P. 34

Literatur
      • Van Matre ET, Satyanarayana G, Page 2nd RL, Levi ME, Lindenfeld J,
       Mueller SW� Pharmacokinetic Drug-Drug Interactions Between
       Immunosuppressant and Anti-Infective Agents: Antimetabolites
       and Corticosteroids� Ann Transplant 2018;23:66-74�
      • Kovarik JM, Eisen H, Dorent et al� Everolimus in de novo
       cardiac transplantation: pharmacokinetics, therapeutic
       range, and influence on Ciclosporine exposure� J Heart
       Lung Transplant 2003; 22:1117-1125�
      • Kovarik JM, Curtis JJ, Hricik DE, et al� Differential
       pharmacokinetic interaction of tacrolimus and Ciclosporine
       on everolimus� Transplant Proc� 2006; 38: 3456-3458�
      • Warrington JS, Shaw LM� Pharmacogenetic differences and
       drug-drug interactions in immunosuppressive therapy�
       Expert Opin Drug Metab Toxicol 2005;1:487-503�
      • Masuda S, Inui K� An up-to date review on individualized
       dosage adjustment of calcineurin inhibitors in organ
       transplant patients� Pharmacol Ther 2006; 184-198�
      • Staatz CE, Tett SE� Clinical pharmacokinetics and
       pharmacodynamics of tacrolimus in solid organ transplantation�
       Clin Pharmacokinetics 2004;43: 624-645�


















      32                                     Austrotransplant
   29   30   31   32   33   34   35   36   37   38   39